These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 4849174)
21. [The undesired effect of methaqualone]. Wisliki L Harefuah; 1974 Feb; 86(4):213. PubMed ID: 4828267 [No Abstract] [Full Text] [Related]
22. [Adverse effects of methaqualone]. Med Klin; 1971 Aug; 66(23):1132. PubMed ID: 5561859 [No Abstract] [Full Text] [Related]
23. Erythema multiforme due to methaqualone. Parish LC; Cander L; Witkowski JA Acta Derm Venereol; 1981; 61(1):88-9. PubMed ID: 6164230 [No Abstract] [Full Text] [Related]
24. Methaqualone: efficacy as a hypnotic and side effects. Matthew H Med J Aust; 1971 Sep; 2(10):546. PubMed ID: 5120451 [No Abstract] [Full Text] [Related]
25. [Neurologic disorders in diabetes mellitus--EEG and paresthesia of the leg]. Omura I; Seki K; Kurimura O; Amaki M; Ishibe T Iryo; 1967 Dec; 21(12):1381-92. PubMed ID: 5599331 [No Abstract] [Full Text] [Related]
26. [Posterior chordo-radicular syndrome and chloroiodoquinone]. Tournilhac M; Flori B Nouv Presse Med; 1972 Dec; 1(46):3132. PubMed ID: 4650514 [No Abstract] [Full Text] [Related]
28. [Neurotoxic effects of methaqualone]. Suchenwirth R Nervenarzt; 1973 Nov; 44(11):611-2. PubMed ID: 4773631 [No Abstract] [Full Text] [Related]
29. Methaqualone metabolites. A mass spectrometric investigation of the monohydroxy derivatives of methaqualone. Bogentoft C; Ericsson O; Danielsson B Acta Pharm Suec; 1974 Dec; 11(6):513-22. PubMed ID: 1136777 [No Abstract] [Full Text] [Related]
30. The ban on methaqualone. Pearlman T S Afr Med J; 1978 Apr; 53(14):524. PubMed ID: 566957 [No Abstract] [Full Text] [Related]
31. Neurologic manifestations of myxedema. Edwards GA Med Times; 1968 Nov; 96(11):1125-30. PubMed ID: 5704907 [No Abstract] [Full Text] [Related]
33. Methaqualone. De Alarcon R Br Med J; 1969 Jan; 1(5636):122-3. PubMed ID: 5761820 [No Abstract] [Full Text] [Related]
34. Determination of methaqualone and its metabolites in urine and blood by UV, GC/FID and GC/MS. Liu F; Liu YT; Feng CL; Luo Y Yao Xue Xue Bao; 1994; 29(8):610-6. PubMed ID: 7985519 [TBL] [Abstract][Full Text] [Related]
35. [Clinical study on the tolerance of methaqualone-diphenyhydramine combination]. Fraga Filho C; Toledo JA; Luna LL; Caves WS; Granato PO Hospital (Rio J); 1969 Dec; 76(6):2003-9. PubMed ID: 5309247 [No Abstract] [Full Text] [Related]
36. [Biotransformation of 2-methyl-3-o-tolyl-4(3H)-quinazolinone (Methaqualone). 3. Identification of 6-hydroxy-2-methyl-3-(3'-hydroxy-2'-methyl-phenyl)-4(3H)-quinazolinone as a renal elimination product of Methaqualone]. Preuss FR; Hassler HM Arzneimittelforschung; 1970 Dec; 20(12):1920-2. PubMed ID: 5537097 [No Abstract] [Full Text] [Related]
37. [On t ataxo-telangiectasia syndrome of Louis-Bar]. Shershina NT Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):840-3. PubMed ID: 5364232 [No Abstract] [Full Text] [Related]